University Study Finds That Women Are Often Overmedicated and Suffer More Adverse Side Effects

A new study by University of Chicago and University of California, Berkeley researchers suggests that women are being widely overmedicated — and suffering excess side effects — because drug dosages are calculated based on studies done overwhelmingly on male subjects.

Scientists and medical professionals have long known that women experience more adverse side effects than men, even when drug dosages are adjusted for body weight. These side effects can range from headaches and nausea to bleeding and seizures. But for decades, women were excluded from drug trials due to the false belief that hormone cycles would skew test results.

Since 1993, the National Institutes of Health has mandated that trials should be run on both men and women. But there are thousands of drugs currently on the market that were approved before the 1993 ruling. In the current study, researchers found 86 drugs for which there was clear evidence of sex differences in how the body broke down the drug. For nearly all of these drugs, women metabolized them more slowly than men, leading to higher levels of exposure to the drug; in 96 percent of cases, this resulted in significantly higher rates of adverse side effects in women.

“There are a lot of drugs that are prescribed on a ‘one-size-fits-all’ basis, and it’s clear that this doesn’t always work,” said Brian Prendergast, a psychologist at the University of Chicago and a co-author of the study. “Especially for drugs that we already know have a wide therapeutic range — meaning there’s a wide range of doses that are still effective — we could do a lot better job of titrating dosages with sex in mind.”

The authors call for the FDA to post the gender breakdown of study participants in trial data for future analyses and to specifically label drugs that are already known to have sex differences. The information should also be discussed and included in medical education, the authors recommend.

The study, “Sex Differences in Pharmacokinetics Predict Adverse Drug Reactions in Women,” was published on the website of the journal Biology of Sex Differences. It may be accessed here.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Related Articles

Latest News

Leamor Kahanov Appointed President of Notre Dame de Namur University

Dr. Kahanov became the twentieth president of Notre Dame de Namur University in California on July 1. She previously served as provost at Alvernia University in Pennsylvania, Stockton University in New Jersey, and SUNY Oneonta.

Jennie Sanders to Lead Academic Affairs at Purdue Global

Most recently, Dr. Sanders served as vice president of experiential product management and interim vice president of product and technology at Western Governors University.

Michelle Allmendinger Is the New President of Delta College in Michigan

Dr. Allmendinger began her tenure as the sixth president of Delta College in Michigan on June 29. Prior to her new role, she spent three years as vice president of student affairs at Southeastern Community College in Iowa.

Tatia Daniels Granger Named President of Averett University in Virginia

Most recently, Dr. Granger was a clinical associate professor of organizational behavior at the College of William and Mary in Williamsburg, Virginia.

A Pair of Women Selected to Lead Community Colleges in New England

Susan Rogers was named president of Central Maine College, effective August 10. Hara D. Charlier is the new president of Berkshire Community College in Pittsfield, Massachusetts.

Tenure-Track Assistant Professor of Political Science

Haverford College invites applications for a tenure-track Assistant Professor position in Political Science, with primary specializations in Comparative Politics and Latin America.

Tenure-Track Assistant Professor of Statistics

The Department of Mathematics and Statistics at Haverford College invites applicants for a tenure-track position in applied statistics to begin in the fall of 2027.

Assistant, Associate or Full Professor for Ophthalmology (Research)

The Department of Ophthalmology at Stanford University seeks a highly qualified candidate to join the Department as Assistant, Associate, or Full Professor in the University Tenure or Non-Tenure Line.

Assistant, Associate or Full Professor for Ophthalmology (Clinicians or Clinician-Scientists)

The Department of Ophthalmology at Stanford University is seeking to fill positions several academic board-certified or board-eligible ophthalmologists or optometrists in the general clinical areas of ophthalmology as well as in a variety of sub-specialty areas.

Associate or Full Professor, Cancer Biology

The Department of Microbiology and Molecular Genetics, in the College of Biological Sciences, University of California, Davis, invites applications for tenured Professor at the Associate or Full Professor level in Cancer Biology.